1. Intestinal Colonization Due to Carbapenem-Resistant Enterobacteriaceae Among Hematological Malignancy Patients in India: Prevalence and Molecular Charecterisation
- Author
-
Sonu Tyagi, Arti Kapil, Seema Sood, Hitender Gautam, Amarjeet Kumar, Sameer Bakhshi, Raunak Bir, Manoranjan Mahapatra, Bimal Kumar Das, and Sarita Mohapatra
- Subjects
medicine.medical_specialty ,Hematology ,biology ,business.industry ,Carbapenem-resistant enterobacteriaceae ,biology.organism_classification ,medicine.disease ,Enterobacteriaceae ,Microbiology ,chemistry.chemical_compound ,chemistry ,Bacteremia ,Internal medicine ,Medicine ,Infection control ,Colonization ,Risk factor ,business ,Ertapenem - Abstract
Faecal carriage of Carbapenem-resistant Enterobacteriaceae (CRE) is being observed as an important risk factor for bacteremia among patients with hematological malignancies. A prospective surveillance study was conducted among these patients to determine the gut colonization of CRE. Rectal/perianal swabs were collected to isolate CRE. Carbapenem resistance was detected by disk diffusion, modified-Hodge, Carba-NP test, and PCR for blaNDM-1, blaKPC, blaOXA-48, blaVIM, blaIMP genes. A total of 209 CRE isolates were identified from 151 patients. E. coli was the most common (83.2%) CRE identified, followed by Klebsiella spp. (9.6%). The majority of CRE were observed resistant to ertapenem (86%). blaNDM-1 was the most common gene (57.3%), followed by blaOXA-48 (37.8%). 26.8% isolates found to carry both blaNDM-1 and blaOXA-48 genes. CRE is increasingly observed to cause bacteremia among hematological malignancy patients due to increased colonization. Screening for gut CRE colonization is necessary to guide empirical therapy and apply infection control measures among these patients.
- Published
- 2021
- Full Text
- View/download PDF